+1 Recommend
2 collections
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impact Assessment of Effectiveness, Acceptance and Usage of AYUSH Advisories and Measures in Prevention of COVID-19 through AYUSH Sanjivani Mobile Application


      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          A bstract


          Ministry of AYUSH deals with developing education, research, and propagation of indigenous traditional medicine systems in India, and in view of public health challenge posed by COVID-19, the ministry had issued preventive and prophylactic advisories.

          Results and discussion

          The advisories issued by Ministry comprises interventions from different AYUSH systems of medicine for preventive health measures and also for boosting immunity during COVID-19 crisis. Further, the Ministry has undertaken study through AYUSH Sanjivani mobile app for generating data of large population with a target of 5 million people. Generation of data on effectiveness, acceptance, and usage of AYUSH advocacies and measures among the population and its impact in the prevention of COVID-19 are the core expected outcomes.


          The present short communication is related to the prophylactic advisories issued by Ministry of AYUSH and details of objectives and expected outcomes of AYUSH Sanjivani mobile application developed by AYUSH Ministry.

          How to cite this article

          Chiluveri AC, Goel S, Rao BCS, et al. Impact Assessment of Effectiveness Acceptance and Usage of AYUSH Advisories and Measures in Prevention of COVID-19 through AYUSH Sanjivani Mobile Application. J Drug Res Ayurvedic Sci 2020;5(1):63–66.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Asian inland wildfires driven by glacial–interglacial climate change

            Significance We reconstructed a unique record of soot variations from a classic Chinese loess section that reflects regional-to-continental scale high-intensity fires in central Asia over the entire Quaternary. This study shows cyclicity of wildfire over glacial–interglacial intervals. High-intensity wildfires were more common and dust loads were high during dry and cold glacial periods, implying a synchronous response to climate change. Our study suggests potential linkages among wildfire, mineral dust, marine biogeochemical cycles, atmospheric CO2, and glacial–interglacial climate change. Understanding these connections among earth systems provides insights into climate dynamics during the geological past and may improve predictions for the future.
              • Record: found
              • Abstract: not found
              • Book: not found

              Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV), (2020)


                Author and article information

                Journal of Drug Research in Ayurvedic Sciences
                Jaypee Brothers Medical Publishers
                January-March 2020
                : 5
                : 1
                : 63-66
                [1 ]Central Ayurveda Research Institute for Cardiovascular Diseases, New Delhi, India
                [2–7,9 ]Central Council for Research in Ayurvedic Sciences, New Delhi, India
                [8 ]Ministry of AYUSH, Government of India, New Delhi, India
                Author notes
                Ashwin C Chiluveri, Central Ayurveda Research Institute for Cardiovascular Diseases, New Delhi, India, e-mail: ashwinayu@yahoo.in
                Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.

                © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                Custom metadata

                General medicine,Immunology,Health & Social care,Public health,Infectious disease & Microbiology,Microbiology & Virology
                AYUSH advocacies,AYUSH Sanjivani COVID-19,Immune boosting measures,Mobile application


                Comment on this article